{
    "2020-05-04": [
        [
            {
                "time": "",
                "original_text": "业绩分化加剧药企淘汰赛提速 盈利能力下降",
                "features": {
                    "keywords": [
                        "业绩分化",
                        "药企",
                        "淘汰赛",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "年报季后，国泰君安上调目标价超过20%的公司名单 | 国君研究",
                "features": {
                    "keywords": [
                        "年报季",
                        "国泰君安",
                        "上调目标价",
                        "超过20%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}